Cart
sales@molnova.com
ranaconitine
CAS No. 1360-76-5
ranaconitine( —— )
Catalog No. M20391 CAS No. 1360-76-5
Ranaconitine is an important diterpenoid alkaloid from Aconitum sinomontanum Nakairanaconitine has cardiotoxicity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 74 | In Stock |
|
| 5MG | 67 | In Stock |
|
| 10MG | 96 | In Stock |
|
| 25MG | 162 | In Stock |
|
| 50MG | 233 | In Stock |
|
| 100MG | 347 | In Stock |
|
| 200MG | 495 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameranaconitine
-
NoteResearch use only, not for human use.
-
Brief DescriptionRanaconitine is an important diterpenoid alkaloid from Aconitum sinomontanum Nakairanaconitine has cardiotoxicity.
-
DescriptionRanaconitine is an important diterpenoid alkaloid from Aconitum sinomontanum Nakairanaconitine has cardiotoxicity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1360-76-5
-
Formula Weight600.7
-
Molecular FormulaC32H44N2O9
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@@]12CC3[C@H](OC)[C@]1(O)[C@](O)(C[C@@H]3OC)[C@@]1(O)C[C@@]3([H])[C@]22[C@@H]1N(CC)C[C@@]3(CC[C@@H]2OC)OC(=O)c1ccccc1NC(C)=O
-
Chemical Name(3S6S7S7aS8S9R10S11aS14S)-1-ethyl-7a11a12-trihydroxy-6810-trimethoxydodecahydro-2H-36a12-(epiethane[112]triyl)-79-methanonaphtho[23-b]azocin-3(4H)-yl 2-acetamidobenzoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nie J Wang F Ji T et al. Assessment of in vitro cardiotoxicity of extract fractions and diterpene alkaloids from Aconitum leucostomum Worosch: A short communication[J]. Journal of Pharmaceutical and Biomedical Analysis 2017 137:84-89.
molnova catalog
related products
-
Guibourtinidin chlor...
Reference standards.
-
Rhodiosin
Rhodiosin is a compound with antioxidant activity.
-
FFAGLDD TFA
FFAGLDD TFA is an MMP9 selective cleavage peptide, which is used for the cytoplasmic transfer of doxorubicin (DOX) to realize the controlled slow drug delivery and release.
